263 related articles for article (PubMed ID: 25164577)
1. Efficacy of budesonide in collagenous colitis Evaluation of: Miehlke S, Madisch A, Kupcinskas L, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014;146(5):1222-1230 e1222.
Drug VL; Antoniu SA
Expert Opin Pharmacother; 2014 Oct; 15(15):2277-9. PubMed ID: 25164577
[TBL] [Abstract][Full Text] [Related]
2. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
Miehlke S; Madisch A; Kupcinskas L; Petrauskas D; Böhm G; Marks HJ; Neumeyer M; Nathan T; Fernández-Bañares F; Greinwald R; Mohrbacher R; Vieth M; Bonderup OK;
Gastroenterology; 2014 May; 146(5):1222-30.e1-2. PubMed ID: 24440672
[TBL] [Abstract][Full Text] [Related]
3. Interventions for treating collagenous colitis.
Chande N; McDonald JW; Macdonald JK
Cochrane Database Syst Rev; 2008 Apr; (2):CD003575. PubMed ID: 18425892
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: budesonide treatment for collagenous colitis.
Feyen B; Wall GC; Finnerty EP; DeWitt JE; Reyes RS
Aliment Pharmacol Ther; 2004 Oct; 20(7):745-9. PubMed ID: 15379834
[TBL] [Abstract][Full Text] [Related]
5. Interventions for treating collagenous colitis.
Chande N; McDonald JW; MacDonald JK
Cochrane Database Syst Rev; 2006 Oct; (4):CD003575. PubMed ID: 17054177
[TBL] [Abstract][Full Text] [Related]
6. Treatment of microscopic colitis: the role of budesonide and new alternatives for refractory patients.
Rojo E; Casanova MJ; Gisbert JP
Rev Esp Enferm Dig; 2020 Jan; 112(1):53-58. PubMed ID: 31880163
[TBL] [Abstract][Full Text] [Related]
7. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial.
Bonderup OK; Hansen JB; Teglbjaerg PS; Christensen LA; Fallingborg JF
Gut; 2009 Jan; 58(1):68-72. PubMed ID: 18669576
[TBL] [Abstract][Full Text] [Related]
8. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials.
Chande N; MacDonald JK; McDonald JW
Am J Gastroenterol; 2009 Jan; 104(1):235-41; quiz 234, 242. PubMed ID: 19098875
[TBL] [Abstract][Full Text] [Related]
9. Oral budesonide therapy improves quality of life in patients with collagenous colitis.
Madisch A; Heymer P; Voss C; Wigginghaus B; Bästlein E; Bayerdörffer E; Meier E; Schimming W; Bethke B; Stolte M; Miehlke S
Int J Colorectal Dis; 2005 Jul; 20(4):312-6. PubMed ID: 15549326
[TBL] [Abstract][Full Text] [Related]
10. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment.
Münch A; Söderholm JD; Ost A; Ström M
Am J Gastroenterol; 2009 Mar; 104(3):679-85. PubMed ID: 19209166
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide.
Miehlke S; Madisch A; Voss C; Morgner A; Heymer P; Kuhlisch E; Bethke B; Stolte M
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1115-9. PubMed ID: 16305725
[TBL] [Abstract][Full Text] [Related]
12. Interventions for treating collagenous colitis: a Cochrane Inflammatory Bowel Disease Group systematic review of randomized trials.
Chande N; McDonald JW; Macdonald JK
Am J Gastroenterol; 2004 Dec; 99(12):2459-65. PubMed ID: 15571596
[TBL] [Abstract][Full Text] [Related]
13. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.
Münch A; Bohr J; Miehlke S; Benoni C; Olesen M; Öst Å; Strandberg L; Hellström PM; Hertervig E; Armerding P; Stehlik J; Lindberg G; Björk J; Lapidus A; Löfberg R; Bonderup O; Avnström S; Rössle M; Dilger K; Mueller R; Greinwald R; Tysk C; Ström M;
Gut; 2016 Jan; 65(1):47-56. PubMed ID: 25425655
[TBL] [Abstract][Full Text] [Related]
14. Collagenous colitis and Crohn's disease: Guilty or innocent bystander?
Silva M; Nunes AC; Andrade P; Gomes S; Macedo G
Dig Liver Dis; 2016 Oct; 48(10):1261-2. PubMed ID: 27474197
[No Abstract] [Full Text] [Related]
15. Smoking Status Influences Clinical Outcome in Collagenous Colitis.
Münch A; Tysk C; Bohr J; Madisch A; Bonderup OK; Mohrbacher R; Mueller R; Greinwald R; Ström M; Miehlke S
J Crohns Colitis; 2016 Apr; 10(4):449-54. PubMed ID: 26721941
[TBL] [Abstract][Full Text] [Related]
16. Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitis.
Bonderup OK; Hansen JB; Madsen P; Vestergaard V; Fallingborg J; Teglbjaerg PS
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1095-9. PubMed ID: 16957516
[TBL] [Abstract][Full Text] [Related]
17. Vedolizumab in Refractory Microscopic Colitis: An International Case Series.
Rivière P; Münch A; Michetti P; Chande N; de Hertogh G; Schoeters P; Ferrante M; Vermeire S; Van Assche G
J Crohns Colitis; 2019 Mar; 13(3):337-340. PubMed ID: 30329034
[TBL] [Abstract][Full Text] [Related]
18. After budesonide, what next for collagenous colitis?
Pardi DS
Gut; 2009 Jan; 58(1):3-4. PubMed ID: 19091826
[No Abstract] [Full Text] [Related]
19. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Hanauer S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytic colitis and collagenous colitis: a review of clinicopathologic features and immunologic abnormalities.
Mahajan D; Goldblum JR; Xiao SY; Shen B; Liu X
Adv Anat Pathol; 2012 Jan; 19(1):28-38. PubMed ID: 22156832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
